Protalix Biotherapeutics Inc (PLX)
Accounts Payable
$6.51M
Quarterly · Period ending: · USD
PLX Accounts Payable
Latest reported$6.51Mperiod ending
Latest reported$6.51Mperiod ending
PLX Quarterly Accounts Payable ($0.00 → $6.51M)
Quarterly accounts payable
High-resolution chart · PNG
PLX accounts payable history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Accounts Payable (USD) |
|---|---|
| 6,506,000 | |
| 4,285,000 | |
| 5,259,000 | |
| 5,375,000 | |
| 6,689,000 | |
| 4,121,000 | |
| 4,533,000 | |
| 3,135,000 | |
| 4,064,000 | |
| 3,146,000 | |
| 4,320,000 | |
| 3,114,000 | |
| 3,304,000 | |
| 5,105,000 | |
| 5,862,000 | |
| 5,639,000 | |
| 6,991,000 | |
| 7,873,000 | |
| 6,986,000 | |
| 8,436,000 | |
| 6,128,000 | |
| 6,376,000 | |
| 7,221,000 | |
| 8,351,000 | |
| 6,707,000 | |
| 9,430,000 | |
| 6,495,000 | |
| 7,755,000 | |
| 6,728,000 | |
| 5,870,000 | |
| 5,211,000 | |
| 4,388,000 | |
| 6,001,000 | |
| 4,872,000 | |
| 7,521,000 | |
| 8,691,000 | |
| 7,852,000 | |
| 5,999,000 | |
| 4,007,000 | |
| 3,989,000 | |
| 3,819,000 | |
| 3,890,000 | |
| 3,629,000 | |
| 4,057,000 | |
| 4,275,000 | |
| 5,195,000 | |
| 3,836,000 | |
| 3,578,000 | |
| 3,592,000 | |
| 4,639,000 | |
| 5,254,000 | |
| 3,313,000 | |
| 3,944,000 | |
| 3,762,000 | |
| 5,267,000 | |
| 4,427,000 | |
| 4,512,000 | |
| 4,568,000 | |
| 5,032,000 | |
| 12,681,000 | |
| 5,847,000 | |
| 7,533,000 | |
| 6,272,000 | |
| 0 | |
| 4,431,000 | |
| 5,429,000 | |
| 3,406,000 | |
| 1,891,000 | |
| 1,982,000 | |
| 1,707,000 | |
| 2,235,000 | |
| 2,067,000 | |
| 1,714,000 | |
| 1,057,000 | |
| 899,000 | |
| 1,359,000 | |
| 867,000 | |
| 788,000 | |
| 892,000 | |
| 12,150 | |
| 13,480 | |
| 0 | |
| 426,000 | |
| 0 | |
| 0 | |
| 4,212 | |
| 4,000 | |
| 4,214 | |
| 67,438 | |
| 61,608 | |
| 78,823 | |
| 63,219 | |
| 61,707 | |
| 81,077 | |
| 79,074 | |
| 65,357 | |
| 61,417 | |
| 70,080 | |
| 77,276 | |
| 60,157 |